002044 Meinian Onehealth Healthcare Holdings
- 4.23
- -0.04-0.94%
Meinian Onehealth Healthcare Holdings News
American Health (002044): The sharp rise in volume and price is in line with expectations, and growth can be expected
American Health (002044): Results quickly resumed in 2023, and the volume and price of the medical examination business rose sharply
American Health (002044): 2023 results are in line with expectations 2024Q1, facing a high base revenue decline, profitability remains steady
American Health (002044): The annual business trend is improving, and data assets have begun to be included in the table
American Health (002044): The trend of increasing customer unit prices in 2023 is evident, and performance is growing strongly
American Health (002044): The trend of increasing customer unit prices in 2023 is evident, and performance is growing strongly
American Health (002044): 2023 results are in line with market expectations, profit side turned loss into profit
American Health (002044): Performance is in line with expectations, the medical examination industry continues to expand, and performance volume and price rise sharply
American Health (002044): Strong rise in volume and price, leading performance growth, development prospects can be expected
Guojin Securities released a research report on April 25 stating that it gave American Health (002044.SZ) a purchase rating. The main reasons for the rating include: 1) the four major brands are developing collaboratively, increasing volume and price to p
American Health (002044): Performance forecasts meet expectations, leading private medical examinations embark on a new journey
American Health (002044) performance forecast review: Excellent performance in the fourth quarter and continued to increase innovative products and AI applications
American Health (002044): Revenue exceeded expectations, medical examination demand recovered as scheduled
MeiNian Health (002044): Equity incentives implemented, performance targets highlight high growth confidence
Research Report Nuggets: Guohai Securities: Maintaining the “buy” rating of American Health, optimistic about the value of the company's preventive medicine platform in the medium to long term
American Health (002044): Equity incentives implemented, long-term growth, full confidence
MeiNian Health (002044): Equity incentives have bright profit targets, and private medical examination leaders once again set sail
MeiNian Health (002044): Good overall operation in the first three quarters and optimistic about long-term growth
American Health (002044): Achieving a basic level of income on a high base, performance in line with expectations
MeiNian Health (002044): The growth rate in the first three quarters was impressive, and the volume and price of the physical examination business rose sharply
Analysis
Price Target
No Data
